Skip to main content
logo
Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS · Delayed Price · Currency is USD
0.006955
+0.000155 (2.28%)
At close: Apr 17, 2026

Petros Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-5.115.825.997.81
Revenue Growth (YoY)
--12.20%-2.83%-23.29%-18.29%
Cost of Revenue
-1.211.632.291.6
Gross Profit
-3.94.193.76.21
Selling, General & Admin
4.648.759.2612.2115.59
Research & Development
-2.622.411.741.79
Operating Expenses
4.6414.214.9519.5524.26
Operating Income
-4.64-10.3-10.76-15.85-18.05
Interest Expense
--0.56-0.54-0.6-0.37
Interest & Investment Income
0.260.370.520.01-
Other Non Operating Income (Expenses)
-0.12-0.872.620.46-
EBT Excluding Unusual Items
-4.5-11.35-8.16-15.97-18.42
Asset Writedown
--2.97--7.46-
Other Unusual Items
---3.399.43
Pretax Income
-4.5-14.32-8.16-20.04-8.99
Earnings From Continuing Operations
-4.5-14.32-8.16-20.04-8.99
Earnings From Discontinued Operations
6.41----
Net Income
1.91-14.32-8.16-20.04-8.99
Preferred Dividends & Other Adjustments
45.612.485.65--
Net Income to Common
-43.69-26.8-13.81-20.04-8.99
Shares Outstanding (Basic)
280000
Shares Outstanding (Diluted)
280000
Shares Change (YoY)
8641.96%268.84%5.11%90.11%103.90%
EPS (Basic)
-1.56-83.47-158.71-241.98-206.31
EPS (Diluted)
-1.56-83.47-158.71-241.98-206.31
Free Cash Flow
-6.73-2.63-7.63-12.8-11.86
Free Cash Flow Per Share
-0.24-8.19-87.62-154.54-272.32
Gross Margin
-76.28%71.98%61.79%79.52%
Operating Margin
--201.41%-184.84%-264.44%-231.05%
Profit Margin
--524.20%-237.26%-334.40%-115.05%
Free Cash Flow Margin
--51.40%-130.99%-213.57%-151.86%
EBITDA
-1.81-7.46-7.48-10.25-11.17
EBITDA Margin
--146.02%-128.46%-171.01%-143.00%
D&A For EBITDA
2.832.833.285.66.88
EBIT
-4.64-10.3-10.76-15.85-18.05
EBIT Margin
--201.41%-184.84%-264.44%-231.05%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.